Journal of Molecular Modeling

, Volume 17, Issue 4, pp 869–877

Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: An in silico analysis

  • Rituraj Purohit
  • Vidya Rajendran
  • Rao Sethumadhavan
Original Paper


Remarkable advances have been made in the drug therapy of tuberculosis. However much remains to be learned about the molecular and structural basis of drug resistance in Mycobacterium tuberculosis. It is known that, activation of Isoniazid (INH) is mediated by Mycobacterium tuberculosis catalase-peroxidase (MtBKatG) and mutation at position 315 (serine to threonine) leads to resistance. We have conducted studies on the drug resistance through docking and binding analysis supported by time-scale (∼1000 ps) and unrestrained all-atom molecular dynamics simulations of wild and mutant MtBKatG. The study showed conformational changes of binding residues. Mutant (S315T) showed high docking score and INH binding affinity as compared to wild enzyme. In molecular dynamics simulation, mutant enzyme exhibited less structure fluctuation at INH binding residues and more degree of fluctuation at C-terminal domain compared to wild enzyme. Our computational studies and data endorse that MtBKatG mutation (S315T) decrease the flexibility of binding residues and made them rigid by altering the conformational changes, in turn it hampers the INH activity. We ascertain from this work that, this study on structural mechanism of resistance development in Mycobacterium tuberculosis would lead to new therapeutics based on the result obtained in this study.


Binding affinity Catalase-peroxidase Docking Isoniazid Molecular dynamic simulation Resistance mutation Solvent accessibility 


  1. 1.
    Zamocky M, Regelsberger G, Jakopitsch C, Obinger C (2001) The molecular peculiarities of catalase-peroxidases. FEBS Lett 492:177–182CrossRefGoogle Scholar
  2. 2.
    Rouse DA, DeVito JA, Li Z, Byer H, Morris SL (1996) Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microbiol 22:583–592CrossRefGoogle Scholar
  3. 3.
    Welinder KG (1991) Bacterial catalase-peroxidases are gene duplicated members of the plant peroxidase superfamily. Biochim Biophys Acta 1080:215–220CrossRefGoogle Scholar
  4. 4.
    Nagy JM, Cass AE, Brown KA (1997) Purification and characterization of recombinant catalase-peroxidase, which confers isoniazid sensitivity in Mycobacterium tuberculosis. J Biol Chem 272:31265–31271CrossRefGoogle Scholar
  5. 5.
    Zhang Y, Garbe T, Young D (1993) Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol 8:521–524CrossRefGoogle Scholar
  6. 6.
    Singh AK, Kumar RP, Pandey N, Singh N, Sinha M, Bhushan A, Kaur P, Sharma S, Singh TP (2010) Mode of binding of the tuberculosis prodrug isoniazid to heme peroxidases: Binding studies and crystal structure of bovine lactoperoxidase with isoniazid at 2.7 A resolution. J Biol Chem 285:1569–1576CrossRefGoogle Scholar
  7. 7.
    Wengenack NL, Rusnak F (2001) Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). Biochemistry 40:8990–8996CrossRefGoogle Scholar
  8. 8.
    Timmins GS, Deretic V (2006) Mechanisms of action of isoniazid. Mol Microbiol 62:1220–1227CrossRefGoogle Scholar
  9. 9.
    Johnsson K, King DS, Schultz PG (1995) Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J Am Chem Soc 117:5009–5010CrossRefGoogle Scholar
  10. 10.
    Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D (2006) Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 50:2640–2649CrossRefGoogle Scholar
  11. 11.
    Marttila HJ, Mäkinen J, Marjamäki M, Soini H (2009) Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur J Clin Microbiol Infect Dis 28:33–38CrossRefGoogle Scholar
  12. 12.
    Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca L de S, Ho JL, Kritski AL, Rossetti ML (2009) Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol 9:39CrossRefGoogle Scholar
  13. 13.
    Ng VH, Cox JS, Sousa AO, MacMicking JD, McKinney JD (2004) Role of KatG catalase-peroxidase in mycobacterial pathogenesis: Countering the phagocyte oxidative burst. Mol Microbiol 52:1291–1302CrossRefGoogle Scholar
  14. 14.
    Marttila HJ, Soini H, Eerola E, Vyshnevskaya E, Vyshnevskiy BI, Otten TF, Vasilyef AV, Viljanen MK (1998) A Ser315Thr substitution KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob Agents Chemother 42(9):2443–2445Google Scholar
  15. 15.
    Yu S, Girotto S, Lee C, Magliozzo RS (2003) Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance. J Biol Chem 278:14769–14775CrossRefGoogle Scholar
  16. 16.
    Zhao X, Yu S, Ranguelova K, Suarez J, Metlitsky L, Schelvis JPM, Magliozzo RS (2009) Role of the oxyferrous heme intermediate and distal side adduct radical in the catalase activity of mycobacterium tuberculosis katg revealed by the w107f mutant. J Biol Chem 284:7030–7037CrossRefGoogle Scholar
  17. 17.
    Ranguelova K, Suarez J, Metlitsky L, Yu S, Brejt SZ, Zhao L, Schelvis JP, Magliozzo RS (2008) Impact of distal side water and residue 315 on ligand binding to ferric Mycobacterium tuberculosis catalase-peroxidase (KatG). Biochemistry 47:12583–12592CrossRefGoogle Scholar
  18. 18.
    Pym AS, Saint-Joanis B, Cole ST (2002) Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 70:4955–4960CrossRefGoogle Scholar
  19. 19.
    Bertrand T, Eady NAJ, Jones JN, Jesmin NJM, Jamart-Gregoire B, Raven EL, Brown KA (2004) Crystal structure of Mycobacterium tuberculosis catalase-peroxidase. J Biol Chem 279:38991–38999CrossRefGoogle Scholar
  20. 20.
    Heym B, Zhang Y, Poulet S, Young D, Cole ST (1993) Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J Bacteriol 175:4255–4259Google Scholar
  21. 21.
    Zhao X, Yu H, Yu S, Wang F, Sacchettini JC, Magliozzo RS (2006) Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant. Biochemistry 45:4131–4140CrossRefGoogle Scholar
  22. 22.
    Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucl Acids Res 28:235–242CrossRefGoogle Scholar
  23. 23.
    Feldman J, Snyder KA, Ticoll A, Pintilie G, Hogue CW (2006) A complete small molecule dataset from the protein data bank. FEBS Lett 580:1649–1653CrossRefGoogle Scholar
  24. 24.
    Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res 33:363–367CrossRefGoogle Scholar
  25. 25.
    Han LY, Lin HH, Li ZR, Zheng CJ, Cao ZW, Xie B, Chen YZ (2006) PEARLS: program for energetic analysis of receptor-ligand system. J Chem Inf Model 46(1):445–450CrossRefGoogle Scholar
  26. 26.
    Chothia C, Janin J (1975) Principles of protein-protein recognition. Nature 256:705–708CrossRefGoogle Scholar
  27. 27.
    Fraczkiewicz R, Braun W (1998) Exact and Efficient Analytical Calculation of the Accessible Surface Areas and Their Gradients for Macromolecules. J Comput Chem 19:319–333CrossRefGoogle Scholar
  28. 28.
    Shrake A, Rupley JA (1973) Environment and exposure to solvent of protein atoms. Lysozyme and Insulin. J Mol Biol 79:351–371CrossRefGoogle Scholar
  29. 29.
    Rodriguez R, Chinea G, Lopez N, Pons T (1998) Vriend G. Homology modeling, model and software evaluation: three related resources. Bioinformatics 14(6):523–528CrossRefGoogle Scholar
  30. 30.
    Hess B, Kutzner C, Spoel D, Lindahl E (2008) GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435–447CrossRefGoogle Scholar
  31. 31.
    Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701–1718CrossRefGoogle Scholar
  32. 32.
    Van Gunsteren WF, Billeter SR, Eising AA, Hunenberger PH, Kruger P, Mark AE, Scott WRP, Tironi TG (1996) Biomolecular simulation: The Gromos 96 Manual and User Guide. Hochschulverlag AG an der Zurich, ZurichGoogle Scholar
  33. 33.
    Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J (1981) In: Pullman B (ed) Interaction models for water in relation to protein hydration. Intermolecular Forces. D Reidel Publishing Company, Dordrecht, pp 331–342Google Scholar
  34. 34.
    Berendsen HJC, Postma JP, van Gunsteren WF, DiNola A, Haak JR (1984) Molecular Dynamics with Coupling to an External bath. J Chem Phys 81:3684–3690CrossRefGoogle Scholar
  35. 35.
    Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh ewald method. J Chem Phys 103:8577–8593CrossRefGoogle Scholar
  36. 36.
    Case DA, Pearlman DA, Caldwell JW, Wang J, Ross WS, Simmerling CL, Darden TA, Mertz KM, Stanton RV, Cheng AL, Vincent JJ, Crowley M, Tsue V, Gohlke H, Radmer R, Duan Y, Pitera J, Massova I, Seibel GL, Singh C, Weiner P, Kollman PA (2002) AMBER7 Simulation Software Package. University of California, San FranciscoGoogle Scholar
  37. 37.
    Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33–38CrossRefGoogle Scholar
  38. 38.
    Emsley P, Cowtan K (2004) Coot: Model-Building Tools for Molecular Graphics. Acta Crystallogr D - Biol Cryst 60:2126–2132CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Rituraj Purohit
    • 1
  • Vidya Rajendran
    • 1
  • Rao Sethumadhavan
    • 1
  1. 1.School of Bio Sciences and Technology (SBST), Bioinformatics DivisionVellore Institute of Technology UniversityVelloreIndia

Personalised recommendations